Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder

Alberto Chiesa, Concetta Crisafulli, Stefano Porcelli, Changsu Han, Ashwin A. Patkar, Soo Jung Lee, Moon Ho Park, Tae Youn Jun, Alessandro Serretti, Chi Un Pae

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The present study is aimed to exploring whether some single nucleotide polymorphisms (SNPs) within GRIA1, GRIA2 and GRIA4 could be associated with major depressive disorder (MDD) and whether they could predict clinical outcomes in Korean in-patients, respectively, treated with antidepressants. One hundred forty-five (145) patients with MDD and 170 healthy controls were genotyped for 17 SNPs within GRIA1, GRIA2 and GRIA4. Baseline and final clinical measures, including the Montgomery-Asberg Depression Rating Scale (MADRS) for patients with MDD, were recorded.No association was observed between alleles, genotypes and haplotypes under investigation and clinical and demographical variables. As a secondary finding, a marginal association was observed between rs4302506 and rs4403097 alleles within GRIA2 and age of onset in patients with MDD. Our findings provide evidence for a possible association between rs4302506 and rs4403097 SNPs and age of onset in patients withMDD. However, taking into account that the several limitations of our study including the moderately small sample size of our study, our findings should be considered with caution and further research is needed to draw more definitive conclusions.

Original languageEnglish
Pages (from-to)305-311
Number of pages7
JournalEuropean Archives of Psychiatry and Clinical Neuroscience
Volume262
Issue number4
DOIs
Publication statusPublished - 2012 Jun 1

Fingerprint

Major Depressive Disorder
Single Nucleotide Polymorphism
Age of Onset
Alleles
Therapeutics
Sample Size
Haplotypes
Antidepressive Agents
Genotype
Depression
Research

Keywords

  • GRIA1
  • GRIA2
  • GRIA4
  • Major depressive disorder

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Pharmacology (medical)

Cite this

Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. / Chiesa, Alberto; Crisafulli, Concetta; Porcelli, Stefano; Han, Changsu; Patkar, Ashwin A.; Lee, Soo Jung; Park, Moon Ho; Jun, Tae Youn; Serretti, Alessandro; Pae, Chi Un.

In: European Archives of Psychiatry and Clinical Neuroscience, Vol. 262, No. 4, 01.06.2012, p. 305-311.

Research output: Contribution to journalArticle

Chiesa, Alberto ; Crisafulli, Concetta ; Porcelli, Stefano ; Han, Changsu ; Patkar, Ashwin A. ; Lee, Soo Jung ; Park, Moon Ho ; Jun, Tae Youn ; Serretti, Alessandro ; Pae, Chi Un. / Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder. In: European Archives of Psychiatry and Clinical Neuroscience. 2012 ; Vol. 262, No. 4. pp. 305-311.
@article{bbfa41238b2d4d6db003e60afebe6f23,
title = "Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder",
abstract = "The present study is aimed to exploring whether some single nucleotide polymorphisms (SNPs) within GRIA1, GRIA2 and GRIA4 could be associated with major depressive disorder (MDD) and whether they could predict clinical outcomes in Korean in-patients, respectively, treated with antidepressants. One hundred forty-five (145) patients with MDD and 170 healthy controls were genotyped for 17 SNPs within GRIA1, GRIA2 and GRIA4. Baseline and final clinical measures, including the Montgomery-Asberg Depression Rating Scale (MADRS) for patients with MDD, were recorded.No association was observed between alleles, genotypes and haplotypes under investigation and clinical and demographical variables. As a secondary finding, a marginal association was observed between rs4302506 and rs4403097 alleles within GRIA2 and age of onset in patients with MDD. Our findings provide evidence for a possible association between rs4302506 and rs4403097 SNPs and age of onset in patients withMDD. However, taking into account that the several limitations of our study including the moderately small sample size of our study, our findings should be considered with caution and further research is needed to draw more definitive conclusions.",
keywords = "GRIA1, GRIA2, GRIA4, Major depressive disorder",
author = "Alberto Chiesa and Concetta Crisafulli and Stefano Porcelli and Changsu Han and Patkar, {Ashwin A.} and Lee, {Soo Jung} and Park, {Moon Ho} and Jun, {Tae Youn} and Alessandro Serretti and Pae, {Chi Un}",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/s00406-011-0270-y",
language = "English",
volume = "262",
pages = "305--311",
journal = "Archiv fur Psychiatrie und Nervenkrankheiten",
issn = "0003-9373",
publisher = "D. Steinkopff-Verlag",
number = "4",

}

TY - JOUR

T1 - Influence of GRIA1, GRIA2 and GRIA4 polymorphisms on diagnosis and response to treatment in patients with major depressive disorder

AU - Chiesa, Alberto

AU - Crisafulli, Concetta

AU - Porcelli, Stefano

AU - Han, Changsu

AU - Patkar, Ashwin A.

AU - Lee, Soo Jung

AU - Park, Moon Ho

AU - Jun, Tae Youn

AU - Serretti, Alessandro

AU - Pae, Chi Un

PY - 2012/6/1

Y1 - 2012/6/1

N2 - The present study is aimed to exploring whether some single nucleotide polymorphisms (SNPs) within GRIA1, GRIA2 and GRIA4 could be associated with major depressive disorder (MDD) and whether they could predict clinical outcomes in Korean in-patients, respectively, treated with antidepressants. One hundred forty-five (145) patients with MDD and 170 healthy controls were genotyped for 17 SNPs within GRIA1, GRIA2 and GRIA4. Baseline and final clinical measures, including the Montgomery-Asberg Depression Rating Scale (MADRS) for patients with MDD, were recorded.No association was observed between alleles, genotypes and haplotypes under investigation and clinical and demographical variables. As a secondary finding, a marginal association was observed between rs4302506 and rs4403097 alleles within GRIA2 and age of onset in patients with MDD. Our findings provide evidence for a possible association between rs4302506 and rs4403097 SNPs and age of onset in patients withMDD. However, taking into account that the several limitations of our study including the moderately small sample size of our study, our findings should be considered with caution and further research is needed to draw more definitive conclusions.

AB - The present study is aimed to exploring whether some single nucleotide polymorphisms (SNPs) within GRIA1, GRIA2 and GRIA4 could be associated with major depressive disorder (MDD) and whether they could predict clinical outcomes in Korean in-patients, respectively, treated with antidepressants. One hundred forty-five (145) patients with MDD and 170 healthy controls were genotyped for 17 SNPs within GRIA1, GRIA2 and GRIA4. Baseline and final clinical measures, including the Montgomery-Asberg Depression Rating Scale (MADRS) for patients with MDD, were recorded.No association was observed between alleles, genotypes and haplotypes under investigation and clinical and demographical variables. As a secondary finding, a marginal association was observed between rs4302506 and rs4403097 alleles within GRIA2 and age of onset in patients with MDD. Our findings provide evidence for a possible association between rs4302506 and rs4403097 SNPs and age of onset in patients withMDD. However, taking into account that the several limitations of our study including the moderately small sample size of our study, our findings should be considered with caution and further research is needed to draw more definitive conclusions.

KW - GRIA1

KW - GRIA2

KW - GRIA4

KW - Major depressive disorder

UR - http://www.scopus.com/inward/record.url?scp=84864927226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864927226&partnerID=8YFLogxK

U2 - 10.1007/s00406-011-0270-y

DO - 10.1007/s00406-011-0270-y

M3 - Article

VL - 262

SP - 305

EP - 311

JO - Archiv fur Psychiatrie und Nervenkrankheiten

JF - Archiv fur Psychiatrie und Nervenkrankheiten

SN - 0003-9373

IS - 4

ER -